BLB&B Advisors LLC lowered its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 6.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 107,816 shares of the company's stock after selling 7,555 shares during the quarter. BLB&B Advisors LLC's holdings in Procter & Gamble were worth $15,451,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Assenagon Asset Management S.A. boosted its stake in Procter & Gamble by 100.8% in the 4th quarter. Assenagon Asset Management S.A. now owns 5,460,939 shares of the company's stock worth $782,607,000 after purchasing an additional 2,741,924 shares during the period. Amundi raised its position in shares of Procter & Gamble by 26.3% during the third quarter. Amundi now owns 10,682,455 shares of the company's stock valued at $1,606,748,000 after buying an additional 2,222,560 shares during the last quarter. Franklin Resources Inc. lifted its holdings in shares of Procter & Gamble by 8.3% in the third quarter. Franklin Resources Inc. now owns 22,850,345 shares of the company's stock worth $3,510,955,000 after buying an additional 1,752,481 shares in the last quarter. Danske Bank A S purchased a new position in shares of Procter & Gamble in the third quarter worth $252,853,000. Finally, Vanguard Group Inc. boosted its position in shares of Procter & Gamble by 0.6% during the third quarter. Vanguard Group Inc. now owns 234,630,605 shares of the company's stock worth $36,050,992,000 after acquiring an additional 1,419,322 shares during the last quarter. Institutional investors own 65.77% of the company's stock.
Procter & Gamble Price Performance
Procter & Gamble stock opened at $144.39 on Wednesday. Procter & Gamble Company has a 52-week low of $137.62 and a 52-week high of $171.65. The company has a quick ratio of 0.51, a current ratio of 0.72 and a debt-to-equity ratio of 0.49. The firm's fifty day moving average is $152.63 and its 200 day moving average is $149.09. The company has a market cap of $335.56 billion, a price-to-earnings ratio of 21.39, a PEG ratio of 5.48 and a beta of 0.41.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Friday, January 23rd. The company reported $1.88 EPS for the quarter, topping analysts' consensus estimates of $1.86 by $0.02. The business had revenue of $22.21 billion during the quarter, compared to analysts' expectations of $22.36 billion. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The business's revenue was up 1.5% on a year-over-year basis. During the same period last year, the company posted $1.88 EPS. Sell-side analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Insider Buying and Selling
In other news, insider Moses Victor Javier Aguilar sold 15,169 shares of the firm's stock in a transaction that occurred on Friday, February 13th. The stock was sold at an average price of $162.28, for a total value of $2,461,625.32. Following the completion of the sale, the insider directly owned 44,735 shares of the company's stock, valued at $7,259,595.80. This trade represents a 25.32% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Chairman Jon R. Moeller sold 162,232 shares of the business's stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $162.45, for a total value of $26,354,588.40. Following the transaction, the chairman directly owned 319,385 shares in the company, valued at approximately $51,884,093.25. This represents a 33.68% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 348,618 shares of company stock valued at $55,462,643 in the last quarter. 0.20% of the stock is currently owned by insiders.
Analysts Set New Price Targets
PG has been the subject of several research analyst reports. Dbs Bank raised shares of Procter & Gamble from a "hold" rating to a "buy" rating in a research note on Friday, January 23rd. Raymond James Financial dropped their price objective on shares of Procter & Gamble from $175.00 to $170.00 and set an "outperform" rating for the company in a report on Tuesday. Wells Fargo & Company cut their price objective on Procter & Gamble from $177.00 to $158.00 and set an "overweight" rating for the company in a research report on Wednesday, April 8th. Jefferies Financial Group raised Procter & Gamble from a "hold" rating to a "buy" rating and lifted their target price for the stock from $156.00 to $179.00 in a report on Tuesday, December 16th. Finally, Bank of America decreased their target price on Procter & Gamble from $171.00 to $167.00 and set a "buy" rating on the stock in a research report on Friday, April 10th. Twelve equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $163.16.
View Our Latest Stock Analysis on Procter & Gamble
Procter & Gamble News Summary
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: P&G’s board raised the quarterly dividend (to $1.0885/share), extending its dividend-growth streak—a clear positive for income and defensive-income investors. P&G Declares Dividend Increase for April 2026
- Positive Sentiment: P&G is showcasing an AI-driven, decision-centric supply-chain project with OMP at Gartner’s symposium — potential for faster decisions, lower inventory costs and better in-market availability over time. P&G and OMP Showcase the Path to Autonomous, Decision-Centric Planning
- Positive Sentiment: Beauty segment showing ~4% growth driven by premium innovation — a near-term revenue/ margin bright spot that supports upside vs. slower categories. Procter & Gamble's Beauty Strength vs. Baby Care Weakness
- Neutral Sentiment: Analysts remain mixed: some firms trimmed price targets but kept favorable ratings (e.g., Raymond James cut its PT to $170 but kept Outperform), signaling confidence in P&G’s long-term profile despite near-term caution. Raymond James adjusts price target
- Negative Sentiment: Baby Care is underperforming due to inventory headwinds, which pressured revenue in the category and could slow near-term top-line momentum until channel destocking eases. Beauty vs Baby Care analysis
- Negative Sentiment: Barclays and other shops trimmed price targets and ratings (Barclays to $146/equal weight; Piper Sandler cut its PT), reflecting reduced upside expectations and exerting downward pressure on sentiment. Barclays price target cut
- Negative Sentiment: Media reports note Texas consumer-product probes (PFAS inquiries) have touched the sector and referenced P&G in broader coverage — a reputational/regulatory risk to monitor. PFAS investigation coverage
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A forward-looking investment report spotlighting the seven space companies best positioned to benefit from accelerating commercialization in 2026. It explores key industry trends, major growth catalysts, and the stocks shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.
Get This Free Report